Actively Recruiting

Age: 18Years +
All Genders
ID02258724

Swiss National Registry of Adults With Congenital Heart Disease to Collect Long-Term Health Data

Led by University Hospital, Basel, Switzerland · Updated on 2026-05-04

5000

Participants Needed

6

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting detailed health information about adults who were born with congenital heart disease and are being treated in specialized centers in Switzerland. This registry study aims to better understand long-term complications and treatment outcomes for this growing population, as advances in pediatric heart care have allowed most children with congenital heart defects to reach adulthood. The study is observational and focuses on gathering data rather than testing treatments. Participants in this study will have their medical data, including diagnoses, previous treatments, and any cardiac complications, recorded after each visit to a participating center. The information is entered securely into a web-based database to create a nationwide registry. This registry will help provide a clearer picture of the adult congenital heart disease population in Switzerland and improve knowledge about their long-term health outcomes. During the study, participants' health status will be monitored annually for up to 20 years, with a focus on tracking cardiac complications and mortality. The study involves routine clinical visits where data is collected based on patients' ongoing care. The registry helps researchers understand the health trends and risks in this group over time without altering usual medical care.

CONDITIONS

Brief Title

Swiss National Registry of Adults With Congenital Heart Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult (above 18 years of age) with congenital heart disease, treated in one of the Swiss centres specialized for GUCH patients
  • Signed informed consent form
  • For patients with trisomy 21, consent must be given by parents or legal guardian
Not Eligible

You will not qualify if you...

  • None

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surveillance

Duration - Up to 20 years

Participants who undergo routine care are observed to collect long-term health data including cardiac complications and mortality.

Annual visits for up to 20 years

Trial Site Locations

Total: 6 locations

1

Basel University Hospital

Basel, Switzerland, 4031

Actively Recruiting

2

Bern University Hospital Inselspital

Bern, Switzerland, 3010

Actively Recruiting

3

Hôpitaux Universitaires de Genève HUG

Geneva, Switzerland, 1205

Actively Recruiting

4

Centre Hospitalier Universitaire Vaudois CHUV

Lausanne, Switzerland, 1011

Actively Recruiting

5

Kantonsspital St.Gallen

Sankt Gallen, Switzerland, 9007

Actively Recruiting

6

University Hospital Zurich

Zurich, Switzerland, 8091

Actively Recruiting

Loading map...

Research Team

D

Daniel Tobler, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A 10-Minute Cardiovascular Magnetic Resonance Protocol for C...

Coronary Artery Disease

Actively Recruiting

1 location

Evaluation of Surgical Techniques and Outcomes Across the Li...

Congenital Heart Disease

Actively Recruiting

1 location

A Comprehensive Registry Study of the Whole Life Cycle of Pa...

Congenital Heart Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium.

Philip Moons, Lore Bovijn, Werner Budts...

https://pubmed.ncbi.nlm.nih.gov/21098444